Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study
- 22 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 17 (12) , 1361-1367
Abstract
Increasing evidence suggests involvement of the amount of liver fat in the development of cardiovascular disease. We investigated the relation of liver fat with cardiovascular risk factors and subclinical vascular disease in the general population. Between 2003 and 2006, 2351 persons from the population-based Rotterdam Study (mean age 69.6 ± 6.7 years, 47.2% males) underwent non-enhanced computed tomography. We measured the mean liver attenuation value in Hounsfield units and quantified the following markers of subclinical vascular disease: epicardial fat volume and volumes of coronary (CAC), aortic (AAC), extracranial (ECAC), and intracranial carotid calcification (ICAC). Using linear regression, we investigated associations between traditional cardiovascular risk factors and mean liver attenuation. We also investigated relations of mean liver attenuation with markers of subclinical vascular disease, adjusting for cardiovascular risk factors. We found strong associations of waist circumference, diastolic blood pressure, and diabetes with lower mean liver attenuation [multivariable-adjusted beta per unit increase in waist circumference: −2.54 (95% CI: −3.10; −1.99); diastolic blood pressure: −0.52 (95% CI: −0.88; −0.17); and the presence of diabetes: −21.91 (95% CI: −31.76; −12.06)]. Moreover, we found that larger mean liver attenuation values were associated with smaller volumes of epicardial fat and CAC, independent of cardiovascular risk factors [beta per 1-SD increase in mean liver attenuation value: −0.05 (95% CI: −0.08; −0.02) and −0.05 (95% CI: −0.10; −0.01), respectively]. Larger amounts of liver fat are related to larger volumes of epicardial fat and CAC, independent of traditional cardiovascular risk factors, providing important novel insights into the role of liver fat as a marker of vascular disease.Keywords
Funding Information
- Erasmus MC and Erasmus University Rotterdam
- Netherlands Organization for Scientific Research
- Netherlands Organization for Health Research and Development
- Research Institute for Diseases in the Elderly
- Netherlands Genomics Initiative
- Ministry of Education
- Culture and Science
- Ministry of Health
- Welfare and Sports
- European Commission
- Municipality of Rotterdam
This publication has 35 references indexed in Scilit:
- Automatic quantification of epicardial fat volume on non‐enhanced cardiac CT scans using a multi‐atlas segmentation approachMedical Physics, 2013
- Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam studyJournal of Hepatology, 2012
- The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular RiskDigestive Diseases and Sciences, 2009
- Fatty LiverArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Comparison of CT Methods for Determining the Fat Content of the LiverAmerican Journal of Roentgenology, 2007
- Non‐alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickensDiabetic Medicine, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001